Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib

scientific article published on August 2008

Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/THY.2007.0325
P932PMC publication ID2752272
P698PubMed publication ID18651822
P5875ResearchGate publication ID51425326

P2093author name stringRichard P Phipps
Ajay E Kuriyan
Steven E Feldon
Charles W O'Loughlin
P2860cites workThe putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathyQ33805983
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patientsQ35216491
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytesQ35222158
The relation of Graves' ophthalmopathy to circulating thyroid hormone statusQ35591694
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.Q35606170
15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathwayQ43860751
Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.Q44256446
Human lupus T cells resist inactivation and escape death by upregulating COX-2.Q48022316
Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.Q53611171
Pathogenesis of Graves' ophthalmopathyQ70513409
Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expressionQ78767586
Overexpression of immediate early genes in active Graves' ophthalmopathyQ81802760
P433issue8
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)911-914
P577publication date2008-08-01
P1433published inThyroidQ15709940
P1476titleImprovement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib
P478volume18

Reverse relations

cites work (P2860)
Q27691806Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.
Q37296579Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype
Q35055573Salinomycin and other polyether ionophores are a new class of antiscarring agent

Search more.